Navigation Links
Charleston Laboratories, Inc. beginnt mit klinischer Phase 3-Studie für CL-108
Date:1/28/2013

zieren. Die neuen Produkte von Charleston richten sich insbesondere an die Symptome opioidinduzierte Übelkeit oder Erbrechen (OINV), postoperative Übelkeit und Erbrechen (PONV), Übelkeit und Erbrechen durch Chemotherapie (CINV), Übelkeit und Erbrechen durch Strahlentherapie sowie Übelkeit und Erbrechen durch Migräne (MINV). Darüber hinaus entwickelt Charleston weitere Produkte ohne Paracetamol, um die Gefahr einer Leberschädigung zu reduzieren, und arbeitet an Formulierungen zur Verhinderung falschen Gebrauchs oder Missbrauchs. Charleston Laboratories plant Partnerschaften zur Forschung und Vermarktung mit Unternehmen, die an neuen Schmerztherapien interessiert sind, welche Übelkeit und Erbrechen deutlich reduzieren.

www.charlestonlabs.com.


'/>"/>
SOURCE Charleston Laboratories, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Abuse Deterrent Medicines Developer Pisgah Laboratories, Inc. Wins Top 5 Technologies Award from CLAAD
2. Abuse-Deterrent Medication Developer, Pisgah Laboratories, Achieves Top 5 Technologies Ranking
3. Pisgah Laboratories, Inc. Scores a Triple Play in the World Series Against Prescription Drug Abuse
4. IncellDx, Inc. Announces an Agreement with BioReference Laboratories, Inc. to Conduct a 10,000 Sample Study Using a Slideless Pap Smear
5. Everett Laboratories, Inc. Files Patent Infringement Lawsuit Against Competitor Trigen Laboratories, Inc.
6. Metabolic Solutions Development Company announces publication of Phase 2b data in Clinical Pharmacology & Therapeutics
7. Vanda Announces Positive Results in the Second Phase III Study (RESET) of Tasimelteon for the Treatment of Non-24-Hour Disorder
8. EntreMed Announces Initiation Of Phase 2 Trial In Advanced/Metastatic Soft Tissue Sarcoma
9. Omeros Announces Positive OMS302 Safety Data in Phase 3 Clinical Trial
10. Boehringer Ingelheim Enrolls First Patients in Pivotal Phase 3 Interferon-Free Hepatitis C Trial Program
11. Phase 3 Topical Drug for Raynauds Disease Available for Licensing/Acquisition at the J.P. Morgan Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... Research and ... of the "Investigation Report on China,s ... offering. Non-steroidal anti-inflammatory drug (NSAID) ... steroids which have a similar anti-inflammatory antirheumatic ... antipyretic effects with fewer side effects compared ...
(Date:9/3/2015)... 3, 2015  CVS Health Corporation (NYSE: CVS ... company,s president and chief executive officer, and Dave ... will be speaking to investors at the Morgan Stanley ... are scheduled to speak at approximately 8:00 a.m. (EDT). ... be broadcast simultaneously through the Investor Relations portion of ...
(Date:9/3/2015)... 03, 2015 Research and ... the "Investigation Report on China Tropisetron Market, 2010-2019" ... by Novartis, entered the market in the ... market in the late 1990s. Tropisetron got administrative protection ... its original developer Sandoz submitted application. But it is ...
Breaking Medicine Technology:China Flurbiprofen Market Investigation Report 2010-2019 2China Tropisetron (Novartis) Market Report 2015-2019 2
... Identification, Characterization and Broad,Neuroprotective Properties of TRO19622 ... Neurodegenerative Disease Specialists Publish Details of a ... Proteins , MARSEILLE, June 19th, 2007 - ... discovery and development of drugs for,neurological disorders, ...
... of Fat, Protein and Other Nutrients in,Patients ... Symptoms of Exocrine Pancreatic Insufficiency, MILAN, Italy ... Eurand N.V. today announced results that,were presented ... in Antalya, Turkey, held June 13-16. Results ...
Cached Medicine Technology:Trophos Publishes ALS Article in Journal of Pharmacology and,Experimental Therapeutics 2Trophos Publishes ALS Article in Journal of Pharmacology and,Experimental Therapeutics 3Trophos Publishes ALS Article in Journal of Pharmacology and,Experimental Therapeutics 4Eurand's Zentase Effective in Treating Exocrine Pancreatic,Insufficiency, Studies Show 2Eurand's Zentase Effective in Treating Exocrine Pancreatic,Insufficiency, Studies Show 3Eurand's Zentase Effective in Treating Exocrine Pancreatic,Insufficiency, Studies Show 4Eurand's Zentase Effective in Treating Exocrine Pancreatic,Insufficiency, Studies Show 5Eurand's Zentase Effective in Treating Exocrine Pancreatic,Insufficiency, Studies Show 6Eurand's Zentase Effective in Treating Exocrine Pancreatic,Insufficiency, Studies Show 7Eurand's Zentase Effective in Treating Exocrine Pancreatic,Insufficiency, Studies Show 8
(Date:9/3/2015)... ... September 03, 2015 , ... ... of comprehensive eating disorder treatment for adults and adolescents struggling with anorexia, ... MD has joined the medical treatment team. As a Staff Psychiatrist, Dr. ...
(Date:9/3/2015)... ... September 03, 2015 , ... According to an Oncology Nurse Advisor ... may help patients with oropharyngeal cancer (oral cancer) to be successfully diagnosed and treated ... caused by HPV infections, which have a high rate of success in treatment and ...
(Date:9/3/2015)... ... 03, 2015 , ... Atlantic Information Services, Inc. (AIS) is ... Strategies for a Rapidly Changing Marketplace.” In this Sept. 16 program, pharmacy benefit ... how plan sponsors are adopting bold, innovative strategies to control soaring specialty pharmacy ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... endpoint data collection, cloud analytics and workflow solutions today announced the complete ... Portugal, September 22-24, 2015. The esteemed faculty of worldwide pharmaceutical and industry ...
(Date:9/3/2015)... ... September 03, 2015 , ... A scar is an unavoidable result of incision or injury to ... body's ability to heal itself. The appearance of a scar is dependent on many factors ... and skin pigmentation. ”Many scars fade to near invisibility on their own over a period ...
Breaking Medicine News(10 mins):Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 2Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 3Health News:LA Periodontists Discuss Study on Post-Treatment Oral Rinses Used to Test Recurrence of Oral Cancers 2Health News:LA Periodontists Discuss Study on Post-Treatment Oral Rinses Used to Test Recurrence of Oral Cancers 3Health News:Speakers for Upcoming AIS Virtual Conference on Pharmacy Benefit Strategies Include Executives from CVS Health, Express Scripts 2Health News:ERT Announces Final Agenda, Faculty for European PRO / eCOA Congress 2Health News:ERT Announces Final Agenda, Faculty for European PRO / eCOA Congress 3Health News:Do I Have To Live With That Scar? 2Health News:Do I Have To Live With That Scar? 3Health News:Do I Have To Live With That Scar? 4
... be an effective therapy to treat and even prevent allergy ... patients with cystic fibrosis and asthma, according to researchers from ... School of Medicine and Louisiana State University School of Medicine., ... a lung disease researcher at Children,s Hospital and professor of ...
... novel mechanism used by adenovirus to sidestep the cell,s suicide ... suppressor genes are silenced in tumor cells and pave the ... researchers at the Salk Institute for Biological Studies in the ... a cell is under stress, the tumor suppressor p53 springs ...
... HealthDay Reporter , WEDNESDAY, Aug. 25 (HealthDay News) ... by a U.S. judge to halt any expansion of ... injunction, which basically blindsided the scientific community, effectively takes ... That was when then-President George W. Bush ordered that ...
... , TUESDAY, Aug. 24 (HealthDay News) -- Adding therapy ... attention-deficit/hyperactivity disorder (ADHD) could lessen symptoms and improve quality ... year, patients receiving cognitive behavioral therapy along with their ... relaxation exercises. "We have known that therapy helps, ...
... surge of scientific research has uncovered telltale signs of ... spinal taps, many questions remain unanswered about the clinical ... patient care, according to Dr. Kenneth S. Kosik, Harriman ... and co-director of UCSB,s Neuroscience Research Institute. Kosik, ...
... Reinberg HealthDay Reporter , TUESDAY, Aug. 24 ... health benefits of drinking continues to bubble, a new ... higher mortality risk than moderate drinkers. "This ... association between moderate alcohol intake and health benefits with ...
Cached Medicine News:Health News:Vitamin D may treat and prevent allergic reaction to mold in cystic fibrosis patients 2Health News:Use the common cold virus to target and disrupt cancer cells? 2Health News:Use the common cold virus to target and disrupt cancer cells? 3Health News:Obama to Appeal Stem Cell Ruling 2Health News:Obama to Appeal Stem Cell Ruling 3Health News:Cognitive Therapy Helps Adults With ADHD 2Health News:Are early testing and drug development the most pressing issues in Alzheimer's care? 2Health News:A Little Drinking Cuts Death Risk for Older Adults 2Health News:A Little Drinking Cuts Death Risk for Older Adults 3Health News:A Little Drinking Cuts Death Risk for Older Adults 4
... integrated system that will perform venous occlusion ... You no longer need to manually control ... with and without reactive hyperemia are included. ... for measurements and the frequency with which ...
... IS2s DCC camera is optimized for cardiac ... and dual-view planar studies. Resolution and image quality ... ,Access to the front of the gantry is ... exercise bicycles or treadmills for dual view gated ...
... Combination A-Scan/Pachymeter with graphic display and IOL ... A-Scan/Pachymeter combination units include firmware module with ... formulas. Audible tones increase in frequency ... Constant tone when alignment is achieved with ...
The CryoSurgery console is the control center for CryoCath's surgical probe. It is a modular system made up of a console control unit and a tank dolly system. The system can be used as a unit or in s...
Medicine Products: